Multivalent influenza nanoparticle vaccines Grant US-11896662-B2 United States of America 13 Feb 2024
Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV) Grant US-11813324-B2 United States of America 14 Nov 2023
Modified RSV F proteins and methods of their use Grant US-11446374-B2 United States of America 20 Sep 2022
RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES Application EP-3775174-A4 European Patent Office 06 Jul 2022
Vaccine compositions having improved stability and immunogenicity Grant US-11364294-B2 United States of America 21 Jun 2022
Multivalent influenza nanoparticle vaccines Grant US-11278612-B2 United States of America 22 Mar 2022
Vaccine compositions having improved stability and immunogenicity Grant US-11253585-B2 United States of America 22 Feb 2022
Modified RSV F proteins and methods of their use Grant US-11052146-B2 United States of America 06 Jul 2021
Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV) Grant US-10842862-B2 United States of America 24 Nov 2020
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE Application EP-3718566-A1 European Patent Office 07 Oct 2020
VACCINE COMPOSITIONS CHARACTERIZED BY IMPROVED STABILITY AND IMMUNOGENICITY Application RU-2730625-C2 Russian Federation 24 Aug 2020
Vaccine compositions having improved stability and immunogenicity Grant US-10426829-B2 United States of America 01 Oct 2019
VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY Application EP-3344291-A4 European Patent Office 10 Apr 2019
Modified RSV F proteins and methods of their use Application US-10022437-B2 United States of America 17 Jul 2018
HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE Application WO-2017153954-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2017
Modified RSV F proteins and methods of their use Application US-9731000-B2 United States of America 15 Aug 2017
Modified RSV F proteins and methods of their use Application US-9717786-B2 United States of America 01 Aug 2017
Modified RSV F proteins and methods of their use Grant US-9675685-B2 United States of America 13 Jun 2017
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE Application EP-3067064-A1 European Patent Office 14 Sep 2016
SELF-ASSEMBLED NANOPARTICLE VACCINES Application WO-2015048149-A1 World Intellectual Property Organisation (WIPO) 02 Apr 2015
Modified RSV F proteins and methods of their use Grant US-8715692-B2 United States of America 06 May 2014
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE Application EP-2370099-A4 European Patent Office 29 May 2013
MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE Application EP-2370099-A1 European Patent Office 05 Oct 2011